Product Information
ZOLMITRIPTAN 5 MG ODT is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $3.2479 per EA under NDC 68382071782. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 15, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382071782
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA202890FDA Approved
5/15/2013
TE Code
AB
On Market Since
5/16/2013
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 5 MG ODT has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 62.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2479 per EA |
|---|---|
| All-time high | $9.7823 (Jul 15, 2015) |
| All-time low | $2.2733 (Sep 22, 2021) |
| 52-week high | $3.5048 |
| 52-week low | $2.6603 |
| Median price | $4.3813 |
| Average price | $5.4861 |
| Largest weekly change | +91.4% (Jan 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolmitriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG ODT, manufactured by Zydus Pharmaceuticals (USA) Inc., is $3.2479 per EA (NDC 68382071782), effective Sep 30, 2026.
How has the price of ZOLMITRIPTAN 5 MG ODT changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG ODT has declined 62.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG ODT?
Since Nov 28, 2013, the NADAC for ZOLMITRIPTAN 5 MG ODT has ranged from a low of $2.2733 (Sep 22, 2021) to a high of $9.7823 (Jul 15, 2015), with a median of $4.3813 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 5 MG ODT?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLMITRIPTAN 5 MG TABLET, is $1.3533 per EA — about 58% below ZOLMITRIPTAN 5 MG ODT.
Who manufactures ZOLMITRIPTAN 5 MG ODT?
ZOLMITRIPTAN 5 MG ODT (NDC 68382071782) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.